Xiaoran Yang
About Xiaoran Yang
Xiaoran Yang is a Senior Healthcare Analyst at Analysis Group in Los Angeles, with extensive experience in economic modeling and regulatory submissions for pharmaceutical interventions.
Company
Xiaoran Yang is currently employed at Analysis Group in Los Angeles, California. Working as a Senior Healthcare Analyst since 2020, Yang has played a vital role in the company's healthcare analytics division. The Analysis Group is known for its data-driven approach to providing economic, financial, and strategic analysis. Before being promoted to Senior Healthcare Analyst, Xiaoran worked as a Healthcare Analyst from 2019 to 2020 at the same company.
Title
Xiaoran Yang holds the title of Senior Healthcare Analyst at Analysis Group. In this role, Yang has been responsible for leading economic modeling projects, evaluating the economic impact and effectiveness of pharmaceutical interventions, and providing essential training to team members.
Education and Expertise
Xiaoran Yang completed a Master of Public Health (MPH) in Epidemiology at the University of Michigan School of Public Health from 2017 to 2019. Prior to that, Yang participated in an exchange program in Molecular and Cellular Biology at the University of California, Berkeley, in 2016. Xiaoran earned a Bachelor's degree in Biological Science from Sun Yat-Sen University, where Yang studied from 2013 to 2017. Yang also completed high school at Guangdong Experimental High School from 2010 to 2013, focusing on science.
Professional Background
Prior to the current position at Analysis Group, Xiaoran Yang worked in various roles and organizations. These included periods as a Course Project Analyst at the University of Michigan School of Public Health, a Graduate Thesis Researcher at M-LEEaD, and a Research Assistant at UChicago Research Bangladesh. Yang also interned at the Adolescent Health Initiative, Hudson, and the Chinese Center for Disease Control and Prevention. An early role was as a Group Leader for the iGEM Competition in the Greater Boston Area.
Achievements
Xiaoran Yang has successfully led over 10 economic modeling projects evaluating pharmaceutical interventions' economic impact and effectiveness. Additionally, Yang has developed economic sections for FDA dossiers and presented model outcomes at major conferences through abstracts and posters. Another notable achievement includes building RShiny applications to convert Excel-based models into interactive RShiny models, centralizing these on Oracle SQL databases for different countries. Xiaoran has also conducted systematic literature reviews and network-meta-analyses for regulatory submissions and provided training for over 15 people across multiple cases, effectively managing daily client relationships.